COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Max Healthcare Insititute Limited
- Enrollment
- 314
- Locations
- 1
- Primary Endpoint
- COVID-19 Positive Case
- Last Updated
- 5 years ago
Overview
Brief Summary
COVID-19 and liver injury in patients with or without underlying liver disease: A multi-centre retrospective-prospective observational study.
All patients infected with SARS-CoV-2 and admitted to the COVID-19 ward/ICU of Max Hospital Saket (either in East Wing , Max Super Specialty Hospital, Saket or MAX Smart Super Specialty Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective data between 1/4/2020- 30/5/2020 & prospective data from approval till 30/6/2020), will be included
Detailed Description
COVID-19 and liver injury in patients with or without underlying liver disease: A multi-centre retrospective-prospective observational study. All patients infected with SARS-CoV-2 and admitted to the COVID-19 ward/ICU of Max Hospital Saket (either in East Wing , Max Super Specialty Hospital, Saket or MAX Smart Super Specialty Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective data between 1/4/2020- 30/5/2020 \& prospective data from approval till 30/6/2020), will be included Primary objectives 1. To study the prevalence of liver live injury \& factors associated with among patients in-fected with SARS-CoV-2. 2. To study the prevalence of new liver injury and factors associated with it, among patient with underlying liver disease who develops COVD-19. Secondary objectives 1. To correlate the presence and degree of liver dysfunction with the clinical outcomes in these patients. 2. To define the incidence of development of acute liver failure among these patients
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients infected with SARS-CoV-2 and admitted to the COVID-19 ward/ICU of Max Hospital Saket (either in East Wing , Max Super Specialty Hospital, Saket or MAX Smart Super Specialty Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective data between 1/4/2020- 30/5/2020 \& prospective data from approval till 30/6/2020), will be included.
Exclusion Criteria
- •Patients less that 18 years old with COVID-19
- •Pregnant ladies with COVD-19
- •Unwilling to give consent for inclusion
Outcomes
Primary Outcomes
COVID-19 Positive Case
Time Frame: 4-8 weeks
To study the prevalence of new liver injury and factors associated with it, among patient with underlying liver disease who develops COVID-19.
Secondary Outcomes
- COVID-19 Positive Case(4-8 weeks)